Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants
在健康成年受试者中评估脑穿透性RIPK1抑制剂SAR443820（DNL788）的安全性、药代动力学和靶点结合情况
期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13690
Hincelin-Mery, Agnes; Nicolas, Xavier; Cantalloube, Cathy; Pomponio, Robert; Lewanczyk, Pascale; Benamor, Myriam; Ofengeim, Dimitry; Krupka, Emmanuel; Hsiao-Nakamoto, Jennifer; Eastenson, Amy; Atassi, Nazem
